| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tight Junctions | 85 | 2024 | 315 | 17.290 |
Why?
|
| Intestinal Mucosa | 119 | 2024 | 3023 | 10.520 |
Why?
|
| Myosin-Light-Chain Kinase | 44 | 2024 | 100 | 8.520 |
Why?
|
| Epithelial Cells | 48 | 2024 | 3665 | 4.900 |
Why?
|
| Claudins | 17 | 2022 | 115 | 4.260 |
Why?
|
| Permeability | 40 | 2024 | 719 | 3.480 |
Why?
|
| Caco-2 Cells | 47 | 2024 | 368 | 2.450 |
Why?
|
| Colitis | 20 | 2024 | 1229 | 2.230 |
Why?
|
| Actomyosin | 7 | 2024 | 109 | 2.020 |
Why?
|
| Epithelium | 13 | 2021 | 1605 | 1.880 |
Why?
|
| Inflammatory Bowel Diseases | 21 | 2024 | 2421 | 1.830 |
Why?
|
| Cell Membrane Permeability | 14 | 2022 | 575 | 1.810 |
Why?
|
| Actins | 18 | 2024 | 2049 | 1.740 |
Why?
|
| Colon | 22 | 2024 | 1788 | 1.700 |
Why?
|
| Membrane Proteins | 36 | 2022 | 7854 | 1.410 |
Why?
|
| Tumor Necrosis Factor-alpha | 28 | 2024 | 4357 | 1.410 |
Why?
|
| Mucous Membrane | 6 | 2023 | 657 | 1.390 |
Why?
|
| Diarrhea | 11 | 2023 | 1341 | 1.320 |
Why?
|
| Colitis, Ulcerative | 17 | 2023 | 1919 | 1.250 |
Why?
|
| Homeostasis | 6 | 2020 | 3305 | 1.200 |
Why?
|
| Endocytosis | 11 | 2014 | 960 | 1.180 |
Why?
|
| Myosin Light Chains | 16 | 2019 | 121 | 1.100 |
Why?
|
| Animal Experimentation | 2 | 2016 | 46 | 1.070 |
Why?
|
| Bacterial Translocation | 4 | 2018 | 73 | 1.070 |
Why?
|
| Microvilli | 7 | 2020 | 233 | 1.040 |
Why?
|
| Intestinal Diseases | 7 | 2018 | 507 | 1.030 |
Why?
|
| Phosphoproteins | 17 | 2022 | 2441 | 1.020 |
Why?
|
| Animals | 155 | 2024 | 167940 | 1.010 |
Why?
|
| Intestines | 17 | 2022 | 1907 | 0.960 |
Why?
|
| Biomedical Research | 7 | 2024 | 3421 | 0.910 |
Why?
|
| Graft vs Host Disease | 6 | 2019 | 3023 | 0.890 |
Why?
|
| Editorial Policies | 3 | 2018 | 457 | 0.890 |
Why?
|
| Biological Transport | 9 | 2015 | 2087 | 0.890 |
Why?
|
| Up-Regulation | 18 | 2024 | 4127 | 0.840 |
Why?
|
| Lymphocytosis | 2 | 2023 | 119 | 0.840 |
Why?
|
| Gastroenterology | 4 | 2018 | 571 | 0.830 |
Why?
|
| Malabsorption Syndromes | 2 | 2020 | 135 | 0.810 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 3 | 2018 | 345 | 0.810 |
Why?
|
| Mice | 95 | 2024 | 81216 | 0.790 |
Why?
|
| Crohn Disease | 9 | 2022 | 2275 | 0.790 |
Why?
|
| Enterobacteriaceae Infections | 3 | 2023 | 192 | 0.780 |
Why?
|
| Immunity, Mucosal | 5 | 2020 | 481 | 0.780 |
Why?
|
| Phosphorylation | 30 | 2022 | 8314 | 0.760 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2021 | 51 | 0.760 |
Why?
|
| Myosin Type V | 1 | 2020 | 33 | 0.720 |
Why?
|
| Intestinal Absorption | 5 | 2017 | 401 | 0.700 |
Why?
|
| Sigmoid Neoplasms | 1 | 2020 | 54 | 0.700 |
Why?
|
| Mitosis | 3 | 2021 | 1193 | 0.690 |
Why?
|
| Signal Transduction | 33 | 2020 | 23363 | 0.690 |
Why?
|
| Mucolipidoses | 1 | 2020 | 82 | 0.690 |
Why?
|
| Mice, Knockout | 28 | 2024 | 14396 | 0.670 |
Why?
|
| Colonic Neoplasms | 10 | 2021 | 2526 | 0.660 |
Why?
|
| Colonic Polyps | 3 | 2020 | 550 | 0.650 |
Why?
|
| Enterocytes | 10 | 2024 | 220 | 0.630 |
Why?
|
| Cell Membrane | 13 | 2018 | 3683 | 0.630 |
Why?
|
| Intercellular Junctions | 4 | 2017 | 197 | 0.630 |
Why?
|
| Intracellular Space | 2 | 2019 | 197 | 0.630 |
Why?
|
| Gastric Mucosa | 5 | 2020 | 599 | 0.630 |
Why?
|
| Dextran Sulfate | 7 | 2024 | 255 | 0.620 |
Why?
|
| Mice, Inbred C57BL | 42 | 2024 | 22025 | 0.620 |
Why?
|
| Interferon-gamma | 10 | 2014 | 3160 | 0.600 |
Why?
|
| Caspase 3 | 3 | 2019 | 730 | 0.590 |
Why?
|
| Research Personnel | 2 | 2013 | 584 | 0.590 |
Why?
|
| Interleukin-13 | 3 | 2020 | 371 | 0.580 |
Why?
|
| Protein Transport | 13 | 2016 | 1966 | 0.580 |
Why?
|
| Cell Polarity | 6 | 2022 | 638 | 0.570 |
Why?
|
| Periodicals as Topic | 3 | 2018 | 1470 | 0.570 |
Why?
|
| Models, Animal | 5 | 2020 | 2117 | 0.570 |
Why?
|
| Disease Models, Animal | 35 | 2024 | 18134 | 0.570 |
Why?
|
| Adherens Junctions | 4 | 2017 | 89 | 0.560 |
Why?
|
| Myosin Type II | 5 | 2018 | 70 | 0.550 |
Why?
|
| Journal Impact Factor | 1 | 2018 | 156 | 0.540 |
Why?
|
| Career Choice | 2 | 2013 | 755 | 0.530 |
Why?
|
| Interleukins | 2 | 2018 | 782 | 0.520 |
Why?
|
| Microscopy | 1 | 2021 | 881 | 0.520 |
Why?
|
| Jejunum | 9 | 2020 | 472 | 0.520 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2015 | 256 | 0.520 |
Why?
|
| Humans | 179 | 2024 | 760261 | 0.510 |
Why?
|
| Adenocarcinoma | 7 | 2020 | 6310 | 0.510 |
Why?
|
| Colonoscopy | 10 | 2023 | 1387 | 0.500 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2015 | 18 | 0.500 |
Why?
|
| Ion Channels | 2 | 2017 | 1043 | 0.500 |
Why?
|
| Sodium-Glucose Transporter 1 | 8 | 2010 | 112 | 0.490 |
Why?
|
| Salmonella Infections, Animal | 1 | 2015 | 61 | 0.490 |
Why?
|
| Cytoskeleton | 7 | 2022 | 1167 | 0.470 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2017 | 452 | 0.470 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2016 | 253 | 0.460 |
Why?
|
| Salmonella typhimurium | 2 | 2020 | 344 | 0.450 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 831 | 0.450 |
Why?
|
| Mice, Inbred Strains | 1 | 2016 | 1765 | 0.440 |
Why?
|
| Major Histocompatibility Complex | 2 | 2014 | 928 | 0.440 |
Why?
|
| Cell Line | 28 | 2021 | 15626 | 0.440 |
Why?
|
| Escherichia coli Infections | 9 | 2011 | 524 | 0.430 |
Why?
|
| Fluorouracil | 2 | 2020 | 1630 | 0.430 |
Why?
|
| Mice, Transgenic | 23 | 2020 | 9531 | 0.430 |
Why?
|
| Cytokines | 15 | 2024 | 7345 | 0.430 |
Why?
|
| Models, Biological | 15 | 2020 | 9468 | 0.430 |
Why?
|
| Cadherins | 4 | 2017 | 898 | 0.420 |
Why?
|
| Dogs | 12 | 2017 | 3843 | 0.420 |
Why?
|
| Sodium | 7 | 2017 | 1601 | 0.410 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2015 | 663 | 0.400 |
Why?
|
| Cell Proliferation | 9 | 2022 | 10434 | 0.400 |
Why?
|
| Caveolin 1 | 3 | 2013 | 257 | 0.390 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 14 | 4 | 2007 | 9 | 0.390 |
Why?
|
| Apoptosis | 13 | 2021 | 9497 | 0.390 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2013 | 346 | 0.370 |
Why?
|
| Ethanol | 4 | 2015 | 1323 | 0.360 |
Why?
|
| Glucose | 9 | 2019 | 4361 | 0.360 |
Why?
|
| Alternative Splicing | 3 | 2021 | 1091 | 0.360 |
Why?
|
| Gastritis, Hypertrophic | 1 | 2009 | 9 | 0.350 |
Why?
|
| Cell Culture Techniques | 2 | 2020 | 1663 | 0.350 |
Why?
|
| Cytoskeletal Proteins | 7 | 2022 | 1344 | 0.350 |
Why?
|
| Cyclic AMP | 4 | 2019 | 1455 | 0.350 |
Why?
|
| Chlorides | 5 | 2020 | 666 | 0.340 |
Why?
|
| Endotoxins | 3 | 2017 | 521 | 0.340 |
Why?
|
| Cell Movement | 13 | 2021 | 5206 | 0.340 |
Why?
|
| Adhesins, Bacterial | 4 | 2018 | 118 | 0.330 |
Why?
|
| Caveolae | 2 | 2007 | 55 | 0.320 |
Why?
|
| Salmonella Infections | 2 | 2020 | 171 | 0.320 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2020 | 4554 | 0.320 |
Why?
|
| Interferon Regulatory Factors | 2 | 2020 | 260 | 0.310 |
Why?
|
| Chloride-Bicarbonate Antiporters | 5 | 2019 | 103 | 0.300 |
Why?
|
| Pseudomonas aeruginosa | 8 | 2008 | 1275 | 0.300 |
Why?
|
| S-Nitrosoglutathione | 1 | 2007 | 23 | 0.290 |
Why?
|
| Intestine, Small | 7 | 2015 | 1207 | 0.290 |
Why?
|
| Reproducibility of Results | 6 | 2023 | 20048 | 0.290 |
Why?
|
| Microscopy, Fluorescence | 9 | 2010 | 2651 | 0.290 |
Why?
|
| T-Lymphocytes | 10 | 2020 | 10183 | 0.290 |
Why?
|
| Lymphocytes | 1 | 2015 | 2612 | 0.280 |
Why?
|
| Software | 1 | 2021 | 4420 | 0.280 |
Why?
|
| Duodenum | 3 | 2019 | 486 | 0.280 |
Why?
|
| Wound Healing | 8 | 2021 | 2786 | 0.280 |
Why?
|
| Enteropathogenic Escherichia coli | 3 | 2011 | 26 | 0.270 |
Why?
|
| Citrobacter rodentium | 3 | 2023 | 64 | 0.270 |
Why?
|
| Gram-Negative Bacteria | 1 | 2008 | 272 | 0.270 |
Why?
|
| Protein Kinase C | 7 | 2022 | 1201 | 0.260 |
Why?
|
| Cells, Cultured | 15 | 2021 | 18968 | 0.260 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2004 | 440 | 0.260 |
Why?
|
| Lipopolysaccharides | 8 | 2020 | 2214 | 0.260 |
Why?
|
| FMN Reductase | 2 | 2015 | 13 | 0.250 |
Why?
|
| Respiratory Mucosa | 3 | 2018 | 441 | 0.250 |
Why?
|
| Receptors, Tumor Necrosis Factor | 3 | 2006 | 584 | 0.250 |
Why?
|
| Gene Knockdown Techniques | 5 | 2022 | 1617 | 0.250 |
Why?
|
| Immunity, Innate | 3 | 2017 | 3046 | 0.250 |
Why?
|
| PrPC Proteins | 2 | 2015 | 37 | 0.250 |
Why?
|
| RNA, Messenger | 10 | 2022 | 12762 | 0.250 |
Why?
|
| Bacteria | 2 | 2023 | 2196 | 0.250 |
Why?
|
| Killer Cells, Natural | 1 | 2014 | 2204 | 0.250 |
Why?
|
| Lymphocyte Activation | 6 | 2009 | 5498 | 0.240 |
Why?
|
| Enterocolitis | 1 | 2006 | 106 | 0.240 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 1189 | 0.240 |
Why?
|
| Bacterial Toxins | 3 | 2022 | 931 | 0.240 |
Why?
|
| Cell Differentiation | 7 | 2020 | 11480 | 0.240 |
Why?
|
| Physicians | 2 | 2013 | 4590 | 0.240 |
Why?
|
| Probiotics | 2 | 2024 | 377 | 0.230 |
Why?
|
| Protein Binding | 11 | 2016 | 9336 | 0.230 |
Why?
|
| Gastrointestinal Tract | 2 | 2009 | 830 | 0.230 |
Why?
|
| Patch-Clamp Techniques | 2 | 2017 | 932 | 0.230 |
Why?
|
| Enteric Nervous System | 1 | 2007 | 212 | 0.230 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 1811 | 0.230 |
Why?
|
| Biological Transport, Active | 2 | 2018 | 328 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 8498 | 0.220 |
Why?
|
| Dextrans | 2 | 2021 | 574 | 0.220 |
Why?
|
| Antiporters | 3 | 2010 | 278 | 0.220 |
Why?
|
| Microfilament Proteins | 2 | 2020 | 1134 | 0.220 |
Why?
|
| Host-Pathogen Interactions | 3 | 2018 | 1447 | 0.220 |
Why?
|
| Protein Multimerization | 2 | 2018 | 983 | 0.220 |
Why?
|
| Stomach Neoplasms | 1 | 2013 | 1423 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2020 | 2874 | 0.210 |
Why?
|
| Microcystins | 1 | 2022 | 3 | 0.210 |
Why?
|
| Serotonin | 4 | 2009 | 1041 | 0.210 |
Why?
|
| Inflammation | 9 | 2023 | 10757 | 0.210 |
Why?
|
| Biopsy | 8 | 2020 | 6775 | 0.210 |
Why?
|
| Virulence | 7 | 2023 | 1295 | 0.210 |
Why?
|
| Cytokinesis | 1 | 2024 | 172 | 0.210 |
Why?
|
| Pseudolymphoma | 1 | 2002 | 30 | 0.210 |
Why?
|
| Lectins | 4 | 2022 | 485 | 0.200 |
Why?
|
| Myosins | 1 | 2024 | 405 | 0.200 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2019 | 64 | 0.200 |
Why?
|
| Ileal Diseases | 1 | 2002 | 69 | 0.200 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2016 | 482 | 0.200 |
Why?
|
| Tryptophan | 1 | 2024 | 480 | 0.200 |
Why?
|
| Enterovirus B, Human | 2 | 2015 | 47 | 0.200 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2002 | 72 | 0.200 |
Why?
|
| Enzyme Activation | 6 | 2012 | 3604 | 0.200 |
Why?
|
| RNA, Small Interfering | 7 | 2011 | 3443 | 0.190 |
Why?
|
| Organoids | 4 | 2024 | 729 | 0.190 |
Why?
|
| Wnt Proteins | 2 | 2024 | 718 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 8 | 2020 | 6226 | 0.190 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 2 | 2012 | 104 | 0.190 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2022 | 193 | 0.190 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2016 | 326 | 0.190 |
Why?
|
| Adenoma | 2 | 2008 | 2148 | 0.180 |
Why?
|
| Hypopharyngeal Neoplasms | 1 | 2020 | 51 | 0.180 |
Why?
|
| Malnutrition | 2 | 2018 | 638 | 0.180 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5644 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 3 | 2020 | 5784 | 0.180 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 989 | 0.180 |
Why?
|
| Water | 3 | 2017 | 1402 | 0.180 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2020 | 93 | 0.180 |
Why?
|
| NF-kappa B | 5 | 2010 | 2486 | 0.180 |
Why?
|
| Research Design | 1 | 2016 | 6181 | 0.180 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2020 | 139 | 0.180 |
Why?
|
| Tissue Distribution | 4 | 2010 | 2262 | 0.170 |
Why?
|
| Interleukin-15 | 2 | 2018 | 183 | 0.170 |
Why?
|
| Atrophy | 2 | 2023 | 1625 | 0.170 |
Why?
|
| Lymphotoxin beta Receptor | 4 | 2007 | 24 | 0.170 |
Why?
|
| Serine | 2 | 2022 | 831 | 0.170 |
Why?
|
| Liver Diseases, Alcoholic | 2 | 2015 | 156 | 0.170 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2020 | 177 | 0.170 |
Why?
|
| Celiac Disease | 3 | 2018 | 822 | 0.170 |
Why?
|
| Precancerous Conditions | 1 | 2006 | 978 | 0.170 |
Why?
|
| Colon, Sigmoid | 1 | 2020 | 124 | 0.170 |
Why?
|
| Gene Expression | 7 | 2021 | 7592 | 0.170 |
Why?
|
| Dynamins | 2 | 2018 | 138 | 0.170 |
Why?
|
| Female | 44 | 2024 | 391011 | 0.160 |
Why?
|
| Goblet Cells | 1 | 2022 | 299 | 0.160 |
Why?
|
| Astrocytes | 1 | 2007 | 1335 | 0.160 |
Why?
|
| Protein Kinases | 1 | 2006 | 1612 | 0.160 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2019 | 446 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2012 | 3537 | 0.160 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 11902 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2011 | 3735 | 0.160 |
Why?
|
| Cadmium | 1 | 2020 | 215 | 0.160 |
Why?
|
| Ileum | 4 | 2019 | 556 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 8 | 2016 | 2473 | 0.160 |
Why?
|
| Tacrolimus | 1 | 2022 | 730 | 0.160 |
Why?
|
| Organoplatinum Compounds | 1 | 2020 | 410 | 0.160 |
Why?
|
| Computers | 1 | 2021 | 595 | 0.160 |
Why?
|
| Indicators and Reagents | 1 | 2019 | 461 | 0.150 |
Why?
|
| Leucovorin | 1 | 2020 | 639 | 0.150 |
Why?
|
| Calcium | 5 | 2019 | 5726 | 0.150 |
Why?
|
| Chloride Channels | 1 | 2019 | 221 | 0.150 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2018 | 105 | 0.150 |
Why?
|
| Viruses | 1 | 2022 | 376 | 0.150 |
Why?
|
| Lysophospholipids | 1 | 2020 | 339 | 0.150 |
Why?
|
| Membrane Microdomains | 2 | 2010 | 206 | 0.150 |
Why?
|
| Remission Induction | 2 | 2020 | 2394 | 0.150 |
Why?
|
| Oligopeptides | 2 | 2005 | 1188 | 0.150 |
Why?
|
| Integrases | 1 | 2020 | 516 | 0.150 |
Why?
|
| Male | 47 | 2024 | 359413 | 0.150 |
Why?
|
| Mice, Mutant Strains | 2 | 2014 | 1760 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2010 | 4494 | 0.150 |
Why?
|
| Drug Delivery Systems | 3 | 2020 | 2218 | 0.150 |
Why?
|
| Ion Transport | 3 | 2019 | 318 | 0.150 |
Why?
|
| Lactulose | 1 | 2017 | 31 | 0.140 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2002 | 599 | 0.140 |
Why?
|
| Cholesterol | 4 | 2014 | 2925 | 0.140 |
Why?
|
| Receptors, Notch | 2 | 2020 | 742 | 0.140 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2018 | 131 | 0.140 |
Why?
|
| Neoplasm Proteins | 4 | 2019 | 3613 | 0.140 |
Why?
|
| Case-Control Studies | 8 | 2021 | 22041 | 0.140 |
Why?
|
| Gastric Emptying | 1 | 2019 | 243 | 0.140 |
Why?
|
| Interferons | 1 | 2020 | 705 | 0.140 |
Why?
|
| Protozoan Vaccines | 1 | 2016 | 13 | 0.140 |
Why?
|
| Bone Marrow Transplantation | 3 | 2015 | 2696 | 0.140 |
Why?
|
| Blotting, Western | 9 | 2016 | 5039 | 0.140 |
Why?
|
| alpha Catenin | 1 | 2016 | 37 | 0.140 |
Why?
|
| DNA-Binding Proteins | 5 | 2021 | 9590 | 0.140 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 2 | 2009 | 324 | 0.140 |
Why?
|
| Interferon Type I | 1 | 2020 | 559 | 0.140 |
Why?
|
| Lung | 4 | 2018 | 9989 | 0.140 |
Why?
|
| Immunoblotting | 4 | 2015 | 1649 | 0.140 |
Why?
|
| Mannitol | 1 | 2017 | 180 | 0.140 |
Why?
|
| Colectomy | 2 | 2020 | 694 | 0.140 |
Why?
|
| Algorithms | 3 | 2017 | 13967 | 0.140 |
Why?
|
| Sepsis | 2 | 2024 | 2594 | 0.130 |
Why?
|
| Cryptosporidium | 1 | 2016 | 42 | 0.130 |
Why?
|
| Histocytochemistry | 2 | 2017 | 693 | 0.130 |
Why?
|
| Bacteroides Infections | 1 | 2016 | 89 | 0.130 |
Why?
|
| Nephrons | 1 | 2017 | 168 | 0.130 |
Why?
|
| Cysteine Proteases | 1 | 2016 | 20 | 0.130 |
Why?
|
| Cryptosporidiosis | 1 | 2016 | 55 | 0.130 |
Why?
|
| Burns | 3 | 2014 | 1865 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2015 | 4573 | 0.130 |
Why?
|
| Listeria monocytogenes | 1 | 2018 | 249 | 0.130 |
Why?
|
| Escherichia coli | 6 | 2014 | 4223 | 0.130 |
Why?
|
| Anoikis | 2 | 2006 | 48 | 0.130 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2011 | 2509 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2021 | 1152 | 0.130 |
Why?
|
| Hypertension | 1 | 2016 | 8595 | 0.130 |
Why?
|
| beta Catenin | 3 | 2010 | 1043 | 0.130 |
Why?
|
| Severity of Illness Index | 7 | 2020 | 15827 | 0.130 |
Why?
|
| Myeloid Cells | 1 | 2020 | 821 | 0.130 |
Why?
|
| Urothelium | 1 | 2017 | 277 | 0.130 |
Why?
|
| Stress, Physiological | 3 | 2015 | 1395 | 0.130 |
Why?
|
| Electrophysiology | 2 | 2011 | 1265 | 0.120 |
Why?
|
| Alcohol Drinking | 1 | 2008 | 4012 | 0.120 |
Why?
|
| Time Factors | 12 | 2015 | 40133 | 0.120 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 13629 | 0.120 |
Why?
|
| Enzyme Inhibitors | 2 | 2004 | 3726 | 0.120 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 785 | 0.120 |
Why?
|
| Hemolysin Proteins | 1 | 2015 | 114 | 0.120 |
Why?
|
| Symbiosis | 2 | 2014 | 293 | 0.120 |
Why?
|
| Ion Channel Gating | 1 | 2017 | 436 | 0.120 |
Why?
|
| Recombinant Proteins | 7 | 2012 | 6543 | 0.120 |
Why?
|
| rho-Associated Kinases | 5 | 2011 | 281 | 0.120 |
Why?
|
| Disease Susceptibility | 3 | 2024 | 1791 | 0.120 |
Why?
|
| Sulfasalazine | 2 | 2005 | 84 | 0.120 |
Why?
|
| Receptors, Adiponectin | 1 | 2015 | 81 | 0.120 |
Why?
|
| Integrin alpha Chains | 1 | 2015 | 95 | 0.120 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2017 | 192 | 0.120 |
Why?
|
| Organ Specificity | 2 | 2017 | 1955 | 0.120 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2017 | 237 | 0.120 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1739 | 0.120 |
Why?
|
| Transcytosis | 1 | 2014 | 45 | 0.120 |
Why?
|
| Enterovirus Infections | 1 | 2015 | 74 | 0.120 |
Why?
|
| Glutens | 1 | 2016 | 240 | 0.120 |
Why?
|
| Metalloendopeptidases | 1 | 2016 | 394 | 0.120 |
Why?
|
| Virus Internalization | 2 | 2008 | 494 | 0.120 |
Why?
|
| Protein Isoforms | 4 | 2009 | 1697 | 0.120 |
Why?
|
| Adipocytes, White | 1 | 2015 | 91 | 0.120 |
Why?
|
| Kinetics | 4 | 2017 | 6378 | 0.120 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2013 | 50 | 0.110 |
Why?
|
| Diet, Gluten-Free | 1 | 2016 | 280 | 0.110 |
Why?
|
| Stomach | 1 | 2018 | 695 | 0.110 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2014 | 56 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 5 | 2013 | 3800 | 0.110 |
Why?
|
| ADAM Proteins | 1 | 2015 | 240 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2010 | 2866 | 0.110 |
Why?
|
| Peptides | 2 | 2018 | 4358 | 0.110 |
Why?
|
| Mucins | 1 | 2017 | 568 | 0.110 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 734 | 0.110 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2007 | 688 | 0.110 |
Why?
|
| Quality Control | 1 | 2016 | 827 | 0.110 |
Why?
|
| Alcoholic Intoxication | 1 | 2014 | 174 | 0.110 |
Why?
|
| Escherichia coli Proteins | 3 | 2011 | 1066 | 0.110 |
Why?
|
| Autoimmune Diseases | 1 | 2005 | 2250 | 0.110 |
Why?
|
| Cervix Uteri | 1 | 2017 | 585 | 0.110 |
Why?
|
| Immunohistochemistry | 6 | 2017 | 11064 | 0.110 |
Why?
|
| Abdominal Fat | 1 | 2015 | 223 | 0.110 |
Why?
|
| Transfection | 8 | 2009 | 5782 | 0.110 |
Why?
|
| Gonorrhea | 1 | 2017 | 342 | 0.110 |
Why?
|
| Binding Sites | 4 | 2010 | 6050 | 0.110 |
Why?
|
| Cell Communication | 2 | 2015 | 1642 | 0.110 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2020 | 3531 | 0.100 |
Why?
|
| Macrophages | 3 | 2024 | 5745 | 0.100 |
Why?
|
| Amino Acid Sequence | 5 | 2011 | 13456 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2016 | 740 | 0.100 |
Why?
|
| Molecular Sequence Data | 5 | 2011 | 17628 | 0.100 |
Why?
|
| Bifidobacterium | 1 | 2013 | 98 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2019 | 2363 | 0.100 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2008 | 586 | 0.100 |
Why?
|
| Adoptive Transfer | 2 | 2013 | 825 | 0.100 |
Why?
|
| Chemokine CXCL12 | 2 | 2012 | 454 | 0.100 |
Why?
|
| Cation Transport Proteins | 1 | 2015 | 325 | 0.100 |
Why?
|
| Enteritis | 2 | 2015 | 162 | 0.100 |
Why?
|
| Protein Kinase C-alpha | 3 | 2008 | 113 | 0.100 |
Why?
|
| Microscopy, Confocal | 6 | 2015 | 1972 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 7593 | 0.100 |
Why?
|
| Transplantation Chimera | 1 | 2015 | 595 | 0.100 |
Why?
|
| Behavior, Animal | 2 | 2020 | 1861 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 1902 | 0.100 |
Why?
|
| Pseudomonas Infections | 3 | 2008 | 623 | 0.100 |
Why?
|
| Stem Cells | 2 | 2018 | 3525 | 0.100 |
Why?
|
| Microtubules | 3 | 2017 | 1072 | 0.100 |
Why?
|
| Capsaicin | 1 | 2012 | 231 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2014 | 3804 | 0.100 |
Why?
|
| Species Specificity | 1 | 2016 | 2413 | 0.100 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2012 | 87 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 3 | 2012 | 2056 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2011 | 453 | 0.100 |
Why?
|
| Bacteremia | 2 | 2016 | 979 | 0.100 |
Why?
|
| Neutrophils | 3 | 2018 | 3770 | 0.100 |
Why?
|
| Adult | 15 | 2020 | 219847 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 2 | 2009 | 1613 | 0.100 |
Why?
|
| RNA Interference | 3 | 2015 | 2846 | 0.100 |
Why?
|
| Autoantibodies | 2 | 2017 | 2119 | 0.090 |
Why?
|
| Liver | 6 | 2020 | 7512 | 0.090 |
Why?
|
| Drug Resistance, Microbial | 1 | 2014 | 858 | 0.090 |
Why?
|
| Cytoplasm | 3 | 2004 | 1518 | 0.090 |
Why?
|
| Tissue Culture Techniques | 2 | 2010 | 290 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2010 | 2449 | 0.090 |
Why?
|
| Dietary Proteins | 1 | 2016 | 949 | 0.090 |
Why?
|
| Flow Cytometry | 3 | 2020 | 5873 | 0.090 |
Why?
|
| Inflammation Mediators | 3 | 2015 | 1882 | 0.090 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2011 | 38 | 0.090 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2015 | 619 | 0.090 |
Why?
|
| Granular Cell Tumor | 1 | 2011 | 48 | 0.090 |
Why?
|
| TRPV Cation Channels | 1 | 2012 | 243 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 1244 | 0.090 |
Why?
|
| Salpingectomy | 1 | 2011 | 48 | 0.090 |
Why?
|
| Adenosine | 2 | 2006 | 833 | 0.090 |
Why?
|
| Fimbriae, Bacterial | 1 | 2011 | 138 | 0.090 |
Why?
|
| Coronary Artery Disease | 2 | 2021 | 6661 | 0.090 |
Why?
|
| Drug Monitoring | 1 | 2017 | 966 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 580 | 0.090 |
Why?
|
| Acute Lung Injury | 2 | 2015 | 367 | 0.090 |
Why?
|
| Barrett Esophagus | 1 | 2014 | 490 | 0.090 |
Why?
|
| Base Sequence | 4 | 2011 | 12447 | 0.090 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2011 | 235 | 0.090 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 724 | 0.090 |
Why?
|
| Dynamin II | 2 | 2011 | 35 | 0.090 |
Why?
|
| Down-Regulation | 4 | 2013 | 2918 | 0.090 |
Why?
|
| Genes, Reporter | 4 | 2009 | 1531 | 0.090 |
Why?
|
| Diffusion | 2 | 2011 | 814 | 0.090 |
Why?
|
| GATA5 Transcription Factor | 1 | 2009 | 18 | 0.090 |
Why?
|
| Casein Kinase II | 1 | 2010 | 122 | 0.090 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2010 | 317 | 0.090 |
Why?
|
| Computer Simulation | 2 | 2017 | 6210 | 0.090 |
Why?
|
| Caspases | 3 | 2011 | 878 | 0.090 |
Why?
|
| Pneumonia | 2 | 2014 | 2138 | 0.080 |
Why?
|
| Tissue Adhesions | 1 | 2011 | 222 | 0.080 |
Why?
|
| Iron | 2 | 2015 | 1786 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 1395 | 0.080 |
Why?
|
| Middle Aged | 13 | 2020 | 220175 | 0.080 |
Why?
|
| Autoantigens | 1 | 2013 | 877 | 0.080 |
Why?
|
| Reactive Oxygen Species | 3 | 2024 | 2138 | 0.080 |
Why?
|
| Anions | 1 | 2009 | 137 | 0.080 |
Why?
|
| Appendiceal Neoplasms | 1 | 2011 | 155 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2010 | 532 | 0.080 |
Why?
|
| Urease | 1 | 2008 | 39 | 0.080 |
Why?
|
| Kinetochores | 1 | 2010 | 178 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2011 | 2755 | 0.080 |
Why?
|
| Cysteine Endopeptidases | 1 | 2011 | 548 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 3333 | 0.080 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2010 | 119 | 0.080 |
Why?
|
| Interleukin-8 | 2 | 2009 | 698 | 0.080 |
Why?
|
| Forecasting | 1 | 2018 | 2931 | 0.080 |
Why?
|
| Acetaldehyde | 1 | 2008 | 39 | 0.080 |
Why?
|
| Cell Line, Tumor | 9 | 2010 | 16905 | 0.080 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2007 | 277 | 0.080 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2009 | 819 | 0.080 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2008 | 53 | 0.080 |
Why?
|
| Ovariectomy | 1 | 2011 | 611 | 0.080 |
Why?
|
| Multiprotein Complexes | 2 | 2020 | 1120 | 0.080 |
Why?
|
| Periplasmic Binding Proteins | 1 | 2008 | 34 | 0.080 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2017 | 1162 | 0.080 |
Why?
|
| Clathrin | 1 | 2009 | 257 | 0.080 |
Why?
|
| Cats | 1 | 2009 | 976 | 0.080 |
Why?
|
| Toll-Like Receptors | 1 | 2012 | 590 | 0.080 |
Why?
|
| Giardia lamblia | 1 | 2008 | 23 | 0.080 |
Why?
|
| Journalism, Medical | 1 | 2008 | 73 | 0.080 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 1 | 2007 | 26 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 1 | 2012 | 967 | 0.080 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2009 | 224 | 0.080 |
Why?
|
| Antigens, CD | 2 | 2017 | 4002 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2015 | 1765 | 0.080 |
Why?
|
| Antigen Presentation | 1 | 2013 | 1254 | 0.080 |
Why?
|
| Immunosuppressive Agents | 2 | 2020 | 4168 | 0.080 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2008 | 187 | 0.070 |
Why?
|
| Research Support as Topic | 1 | 2012 | 699 | 0.070 |
Why?
|
| Electric Impedance | 4 | 2017 | 751 | 0.070 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2010 | 419 | 0.070 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 1 | 2007 | 14 | 0.070 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2007 | 48 | 0.070 |
Why?
|
| Cytoprotection | 2 | 2006 | 200 | 0.070 |
Why?
|
| Sensitivity and Specificity | 4 | 2017 | 14656 | 0.070 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1500 | 0.070 |
Why?
|
| Colorectal Neoplasms | 3 | 2021 | 6855 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 2002 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2020 | 9283 | 0.070 |
Why?
|
| Plasmids | 2 | 2010 | 2277 | 0.070 |
Why?
|
| Hyaluronic Acid | 1 | 2011 | 482 | 0.070 |
Why?
|
| Hydroxides | 1 | 2007 | 46 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2021 | 12100 | 0.070 |
Why?
|
| Norethindrone | 1 | 2007 | 56 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2015 | 1301 | 0.070 |
Why?
|
| Models, Immunological | 1 | 2009 | 513 | 0.070 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2007 | 222 | 0.070 |
Why?
|
| Mentors | 1 | 2012 | 662 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2020 | 4355 | 0.070 |
Why?
|
| Dynorphins | 1 | 2007 | 82 | 0.070 |
Why?
|
| Heat-Shock Proteins | 2 | 2015 | 795 | 0.070 |
Why?
|
| Infant | 5 | 2019 | 36030 | 0.070 |
Why?
|
| Peristalsis | 1 | 2006 | 59 | 0.070 |
Why?
|
| Fluid Therapy | 1 | 2010 | 593 | 0.070 |
Why?
|
| Cardiac Myosins | 1 | 2007 | 124 | 0.070 |
Why?
|
| Rats | 9 | 2018 | 23695 | 0.070 |
Why?
|
| Crystallography, X-Ray | 3 | 2017 | 1979 | 0.070 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2007 | 251 | 0.060 |
Why?
|
| Phosphatidylcholines | 1 | 2007 | 406 | 0.060 |
Why?
|
| Bacterial Adhesion | 3 | 2017 | 306 | 0.060 |
Why?
|
| Enzyme Induction | 1 | 2006 | 452 | 0.060 |
Why?
|
| Quorum Sensing | 1 | 2007 | 137 | 0.060 |
Why?
|
| Mutation | 7 | 2021 | 29950 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2007 | 421 | 0.060 |
Why?
|
| Receptors, Serotonin, 5-HT4 | 1 | 2005 | 15 | 0.060 |
Why?
|
| Thiazolidines | 1 | 2005 | 69 | 0.060 |
Why?
|
| Aminosalicylic Acids | 1 | 2005 | 37 | 0.060 |
Why?
|
| Porins | 1 | 2005 | 79 | 0.060 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 280 | 0.060 |
Why?
|
| Tissue Fixation | 1 | 2006 | 241 | 0.060 |
Why?
|
| Naphthalenes | 1 | 2006 | 198 | 0.060 |
Why?
|
| Lasers | 2 | 2011 | 952 | 0.060 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2005 | 67 | 0.060 |
Why?
|
| Helicobacter pylori | 1 | 2008 | 377 | 0.060 |
Why?
|
| Glutamine | 1 | 2008 | 576 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 2007 | 1993 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 1078 | 0.060 |
Why?
|
| Technology, Pharmaceutical | 1 | 2005 | 84 | 0.060 |
Why?
|
| Phosphothreonine | 1 | 2004 | 62 | 0.060 |
Why?
|
| Transplantation Conditioning | 1 | 2012 | 1593 | 0.060 |
Why?
|
| Symporters | 1 | 2007 | 361 | 0.060 |
Why?
|
| Transcription Factor AP-1 | 1 | 2006 | 321 | 0.060 |
Why?
|
| Vacuoles | 1 | 2005 | 229 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2020 | 1799 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 2016 | 3822 | 0.060 |
Why?
|
| Immune Tolerance | 1 | 2013 | 2299 | 0.060 |
Why?
|
| Microdissection | 1 | 2004 | 151 | 0.060 |
Why?
|
| Computational Biology | 2 | 2008 | 3504 | 0.060 |
Why?
|
| Mesalamine | 1 | 2005 | 136 | 0.060 |
Why?
|
| Polysaccharides | 1 | 2011 | 1016 | 0.060 |
Why?
|
| Blood Platelets | 1 | 2015 | 2522 | 0.060 |
Why?
|
| Appendicitis | 1 | 2011 | 674 | 0.060 |
Why?
|
| Anti-Ulcer Agents | 1 | 2005 | 113 | 0.060 |
Why?
|
| Exons | 2 | 2009 | 2391 | 0.060 |
Why?
|
| Cell Survival | 4 | 2018 | 5796 | 0.060 |
Why?
|
| Fatty Liver | 2 | 2024 | 777 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2010 | 2823 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 8945 | 0.060 |
Why?
|
| Azepines | 1 | 2006 | 330 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2019 | 42034 | 0.060 |
Why?
|
| Lipids | 1 | 2015 | 3336 | 0.060 |
Why?
|
| Cell Fractionation | 1 | 2004 | 251 | 0.060 |
Why?
|
| Zinc | 1 | 2008 | 690 | 0.060 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2004 | 119 | 0.060 |
Why?
|
| Kidney | 3 | 2015 | 7072 | 0.060 |
Why?
|
| Random Allocation | 3 | 2020 | 2394 | 0.060 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2004 | 62 | 0.060 |
Why?
|
| Quinolones | 1 | 2007 | 377 | 0.060 |
Why?
|
| Computer Systems | 1 | 2005 | 470 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2004 | 150 | 0.050 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 3731 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2007 | 1246 | 0.050 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2006 | 501 | 0.050 |
Why?
|
| Receptors, CXCR4 | 2 | 2024 | 728 | 0.050 |
Why?
|
| Adenosine Monophosphate | 1 | 2005 | 283 | 0.050 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 4814 | 0.050 |
Why?
|
| Prodrugs | 1 | 2005 | 259 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2007 | 1895 | 0.050 |
Why?
|
| Insulin-Secreting Cells | 1 | 2010 | 907 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 1694 | 0.050 |
Why?
|
| Pathology, Clinical | 1 | 2006 | 375 | 0.050 |
Why?
|
| Diet | 1 | 2021 | 8008 | 0.050 |
Why?
|
| DNA Primers | 3 | 2015 | 2819 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 620 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1746 | 0.050 |
Why?
|
| Phylogeny | 1 | 2010 | 2775 | 0.050 |
Why?
|
| Disease Progression | 3 | 2020 | 13505 | 0.050 |
Why?
|
| Fluoresceins | 1 | 2022 | 234 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2005 | 623 | 0.050 |
Why?
|
| Gastroenteritis | 1 | 2004 | 237 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2005 | 484 | 0.050 |
Why?
|
| Niacinamide | 1 | 2024 | 414 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 3451 | 0.050 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2008 | 1129 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2014 | 5640 | 0.050 |
Why?
|
| Extracellular Matrix | 2 | 2006 | 1726 | 0.050 |
Why?
|
| Phenotype | 2 | 2016 | 16543 | 0.050 |
Why?
|
| Weight Loss | 1 | 2013 | 2683 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2008 | 1333 | 0.050 |
Why?
|
| Publishing | 1 | 2008 | 837 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2002 | 389 | 0.050 |
Why?
|
| Tomography, Optical Coherence | 1 | 2014 | 2878 | 0.050 |
Why?
|
| Microscopy, Electron | 2 | 2015 | 2558 | 0.050 |
Why?
|
| Drosophila | 1 | 2008 | 1492 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2007 | 2024 | 0.050 |
Why?
|
| HSP27 Heat-Shock Proteins | 2 | 2015 | 67 | 0.050 |
Why?
|
| Interleukin-6 | 3 | 2018 | 3207 | 0.050 |
Why?
|
| Protein Structure, Quaternary | 1 | 2022 | 428 | 0.050 |
Why?
|
| Mucus | 1 | 2022 | 338 | 0.050 |
Why?
|
| Swine | 2 | 2021 | 5902 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 229 | 0.050 |
Why?
|
| HEK293 Cells | 3 | 2019 | 4264 | 0.040 |
Why?
|
| Cholesterol, Dietary | 1 | 2021 | 224 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2004 | 978 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 10829 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2005 | 1172 | 0.040 |
Why?
|
| Protein Stability | 1 | 2022 | 566 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2005 | 509 | 0.040 |
Why?
|
| Estradiol | 1 | 2007 | 1932 | 0.040 |
Why?
|
| Ions | 1 | 2020 | 261 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 58947 | 0.040 |
Why?
|
| Fas Ligand Protein | 2 | 2010 | 215 | 0.040 |
Why?
|
| PDZ Domains | 2 | 2009 | 23 | 0.040 |
Why?
|
| I-kappa B Proteins | 2 | 2010 | 212 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2008 | 1699 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2023 | 508 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2008 | 2141 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 1483 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11708 | 0.040 |
Why?
|
| Endosomes | 1 | 2022 | 519 | 0.040 |
Why?
|
| Azoxymethane | 2 | 2010 | 35 | 0.040 |
Why?
|
| Cell Adhesion | 3 | 2017 | 3096 | 0.040 |
Why?
|
| HT29 Cells | 2 | 2009 | 190 | 0.040 |
Why?
|
| Child | 3 | 2023 | 79758 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 3448 | 0.040 |
Why?
|
| Intestinal Obstruction | 2 | 2014 | 435 | 0.040 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2018 | 25 | 0.040 |
Why?
|
| Molecular Chaperones | 2 | 2015 | 752 | 0.040 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2018 | 64 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7468 | 0.040 |
Why?
|
| Feeding Behavior | 2 | 2021 | 3185 | 0.040 |
Why?
|
| Antibodies | 2 | 2020 | 2424 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2004 | 1188 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2013 | 3763 | 0.040 |
Why?
|
| Feces | 2 | 2020 | 1466 | 0.040 |
Why?
|
| Protein Folding | 1 | 2022 | 867 | 0.040 |
Why?
|
| Chaperonin 60 | 1 | 2018 | 97 | 0.040 |
Why?
|
| Polymerization | 1 | 2018 | 157 | 0.040 |
Why?
|
| Age Factors | 2 | 2012 | 18415 | 0.040 |
Why?
|
| Thiazoles | 1 | 2005 | 1509 | 0.040 |
Why?
|
| Immunologic Surveillance | 1 | 2018 | 92 | 0.040 |
Why?
|
| Mesoderm | 1 | 2020 | 671 | 0.040 |
Why?
|
| Gastrointestinal Motility | 1 | 2019 | 234 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 6067 | 0.040 |
Why?
|
| Proteins | 2 | 2010 | 6030 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2009 | 2776 | 0.040 |
Why?
|
| Pakistan | 1 | 2018 | 307 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2020 | 654 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2013 | 3076 | 0.040 |
Why?
|
| Cholinergic Agonists | 1 | 2017 | 75 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2006 | 2414 | 0.040 |
Why?
|
| Triglycerides | 2 | 2015 | 2476 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 2009 | 1544 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5793 | 0.030 |
Why?
|
| Pyocyanine | 2 | 2007 | 20 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2010 | 750 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2018 | 446 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2020 | 1340 | 0.030 |
Why?
|
| Carcinogens | 2 | 2010 | 449 | 0.030 |
Why?
|
| Aged | 5 | 2020 | 168995 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2024 | 2208 | 0.030 |
Why?
|
| Oxidants | 2 | 2008 | 169 | 0.030 |
Why?
|
| Serine Proteases | 1 | 2016 | 50 | 0.030 |
Why?
|
| Bacteria, Anaerobic | 1 | 2016 | 70 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 1174 | 0.030 |
Why?
|
| Inulin | 1 | 2015 | 68 | 0.030 |
Why?
|
| Testosterone | 1 | 2007 | 2469 | 0.030 |
Why?
|
| Acute Disease | 1 | 2006 | 7268 | 0.030 |
Why?
|
| Insulin | 1 | 2010 | 6592 | 0.030 |
Why?
|
| Trypsin | 1 | 2016 | 496 | 0.030 |
Why?
|
| Tyrosine | 2 | 2011 | 1440 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 4437 | 0.030 |
Why?
|
| Solubility | 2 | 2011 | 1088 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2006 | 2510 | 0.030 |
Why?
|
| Iron Radioisotopes | 1 | 2015 | 19 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2012 | 1173 | 0.030 |
Why?
|
| Macromolecular Substances | 2 | 2009 | 1433 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 998 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 2282 | 0.030 |
Why?
|
| Acetylcholine | 1 | 2017 | 629 | 0.030 |
Why?
|
| Bacteroides fragilis | 1 | 2016 | 238 | 0.030 |
Why?
|
| Jejunal Diseases | 1 | 2015 | 46 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 471 | 0.030 |
Why?
|
| Isoenzymes | 2 | 2011 | 1690 | 0.030 |
Why?
|
| Atherosclerosis | 2 | 2021 | 3524 | 0.030 |
Why?
|
| RNA | 1 | 2004 | 2721 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2011 | 3105 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2016 | 309 | 0.030 |
Why?
|
| Ampicillin | 1 | 2014 | 141 | 0.030 |
Why?
|
| Cytosol | 2 | 2009 | 887 | 0.030 |
Why?
|
| src-Family Kinases | 2 | 2008 | 534 | 0.030 |
Why?
|
| Cell Count | 1 | 2018 | 1838 | 0.030 |
Why?
|
| United States | 3 | 2020 | 72363 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2007 | 616 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2018 | 547 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 389 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2020 | 3605 | 0.030 |
Why?
|
| Transglutaminases | 1 | 2015 | 197 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 1577 | 0.030 |
Why?
|
| Cholesterol, VLDL | 1 | 2014 | 71 | 0.030 |
Why?
|
| Transferrin | 1 | 2015 | 284 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 6131 | 0.030 |
Why?
|
| Liver Neoplasms | 2 | 2010 | 4317 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 871 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2015 | 522 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2006 | 3242 | 0.030 |
Why?
|
| Italy | 1 | 2015 | 840 | 0.030 |
Why?
|
| Cell Hypoxia | 2 | 2006 | 657 | 0.030 |
Why?
|
| Lymph Nodes | 2 | 2020 | 3491 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2021 | 2937 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2008 | 2415 | 0.030 |
Why?
|
| Dietary Fats | 1 | 2021 | 1992 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2020 | 1334 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2015 | 397 | 0.030 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2015 | 382 | 0.030 |
Why?
|
| Adipokines | 1 | 2015 | 311 | 0.030 |
Why?
|
| Biofilms | 2 | 2008 | 622 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2014 | 391 | 0.030 |
Why?
|
| Biotinylation | 1 | 2012 | 184 | 0.030 |
Why?
|
| Hepatocytes | 2 | 2010 | 1228 | 0.030 |
Why?
|
| Obesity | 1 | 2015 | 12915 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2005 | 2297 | 0.030 |
Why?
|
| Constipation | 1 | 2017 | 561 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2021 | 41317 | 0.030 |
Why?
|
| Rolipram | 1 | 2011 | 24 | 0.020 |
Why?
|
| Stress, Mechanical | 2 | 2008 | 1666 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2012 | 409 | 0.020 |
Why?
|
| Diterpenes | 1 | 2012 | 171 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2014 | 394 | 0.020 |
Why?
|
| Risk Factors | 3 | 2015 | 74269 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2020 | 80301 | 0.020 |
Why?
|
| Platelet Aggregation | 1 | 2015 | 805 | 0.020 |
Why?
|
| Arabinose | 1 | 2011 | 30 | 0.020 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2011 | 34 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2017 | 2608 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 1021 | 0.020 |
Why?
|
| Methylglucosides | 1 | 2010 | 35 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2020 | 2536 | 0.020 |
Why?
|
| Chemical Fractionation | 1 | 2011 | 62 | 0.020 |
Why?
|
| Diarrhea, Infantile | 1 | 2011 | 107 | 0.020 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2017 | 867 | 0.020 |
Why?
|
| Microtubule Proteins | 1 | 2010 | 62 | 0.020 |
Why?
|
| Acrylamides | 1 | 2012 | 260 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 8157 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2015 | 951 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 2895 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2011 | 402 | 0.020 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2011 | 136 | 0.020 |
Why?
|
| Luminescence | 1 | 2011 | 133 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2010 | 74 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 373 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2011 | 420 | 0.020 |
Why?
|
| Ovarian Cysts | 1 | 2011 | 107 | 0.020 |
Why?
|
| Prognosis | 2 | 2021 | 29636 | 0.020 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 2009 | 20 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2009 | 31 | 0.020 |
Why?
|
| X-Rays | 1 | 2011 | 307 | 0.020 |
Why?
|
| Crystallization | 1 | 2011 | 533 | 0.020 |
Why?
|
| Uridine Triphosphate | 1 | 2009 | 28 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2010 | 420 | 0.020 |
Why?
|
| Calcimycin | 1 | 2009 | 213 | 0.020 |
Why?
|
| Regeneration | 1 | 2018 | 1506 | 0.020 |
Why?
|
| Ionophores | 1 | 2009 | 107 | 0.020 |
Why?
|
| Galactosyltransferases | 1 | 2011 | 276 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 999 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2009 | 186 | 0.020 |
Why?
|
| Cell Division | 2 | 2007 | 4462 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2013 | 1493 | 0.020 |
Why?
|
| Rheology | 1 | 2009 | 348 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 2008 | 169 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2009 | 350 | 0.020 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2010 | 177 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2020 | 64947 | 0.020 |
Why?
|
| Pelvic Pain | 1 | 2011 | 298 | 0.020 |
Why?
|
| Sentinel Surveillance | 1 | 2010 | 293 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2020 | 3390 | 0.020 |
Why?
|
| Taurocholic Acid | 1 | 2007 | 43 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 2500 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2008 | 114 | 0.020 |
Why?
|
| Recurrence | 1 | 2020 | 8487 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 2010 | 559 | 0.020 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2010 | 361 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2009 | 251 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2011 | 835 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2007 | 299 | 0.020 |
Why?
|
| Chemokines | 1 | 2012 | 962 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2009 | 670 | 0.020 |
Why?
|
| beta-Cyclodextrins | 1 | 2007 | 67 | 0.020 |
Why?
|
| Vesicular Transport Proteins | 1 | 2010 | 374 | 0.020 |
Why?
|
| Heart | 1 | 2020 | 4392 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 1388 | 0.020 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2007 | 20 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 2671 | 0.020 |
Why?
|
| Rural Population | 1 | 2018 | 2267 | 0.020 |
Why?
|
| Caveolins | 1 | 2007 | 102 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2009 | 459 | 0.020 |
Why?
|
| Tritium | 1 | 2007 | 707 | 0.020 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2010 | 276 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 2009 | 2909 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2009 | 514 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2007 | 72 | 0.020 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2007 | 90 | 0.020 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2007 | 93 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 2007 | 246 | 0.020 |
Why?
|
| Multigene Family | 1 | 2010 | 1079 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12806 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2017 | 5429 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2007 | 151 | 0.020 |
Why?
|
| Carbazoles | 1 | 2008 | 221 | 0.020 |
Why?
|
| Introns | 1 | 2009 | 978 | 0.020 |
Why?
|
| Integrin alphaV | 1 | 2006 | 55 | 0.020 |
Why?
|
| Chickens | 1 | 2008 | 859 | 0.020 |
Why?
|
| Haplorhini | 1 | 2007 | 529 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2008 | 697 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 2010 | 768 | 0.020 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2005 | 15 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2015 | 2525 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2006 | 111 | 0.020 |
Why?
|
| Phlorhizin | 1 | 2005 | 37 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 12281 | 0.020 |
Why?
|
| Phagosomes | 1 | 2007 | 200 | 0.020 |
Why?
|
| Liposomes | 1 | 2010 | 776 | 0.020 |
Why?
|
| beta-Alanine | 1 | 2006 | 82 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 2424 | 0.020 |
Why?
|
| 3-O-Methylglucose | 1 | 2005 | 37 | 0.020 |
Why?
|
| Inosine | 1 | 2006 | 130 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2014 | 7400 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2005 | 14 | 0.020 |
Why?
|
| Purinergic P1 Receptor Antagonists | 1 | 2005 | 45 | 0.020 |
Why?
|
| Theobromine | 1 | 2005 | 14 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2005 | 306 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2007 | 468 | 0.020 |
Why?
|
| Peer Review, Research | 1 | 2008 | 341 | 0.020 |
Why?
|
| Phenylhydrazines | 1 | 2005 | 28 | 0.020 |
Why?
|
| Dopamine | 1 | 2012 | 1583 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2005 | 186 | 0.020 |
Why?
|
| Theophylline | 1 | 2005 | 131 | 0.020 |
Why?
|
| Gentamicins | 1 | 2006 | 252 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2005 | 237 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 685 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2005 | 188 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 2797 | 0.020 |
Why?
|
| Chloramines | 1 | 2004 | 15 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 732 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2005 | 173 | 0.020 |
Why?
|
| Anxiety | 1 | 2020 | 4532 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2011 | 901 | 0.020 |
Why?
|
| Chromans | 1 | 2005 | 117 | 0.020 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2004 | 41 | 0.020 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2005 | 119 | 0.020 |
Why?
|
| Phospholipase C gamma | 1 | 2005 | 130 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2007 | 453 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2019 | 6375 | 0.020 |
Why?
|
| Gastrointestinal Contents | 1 | 2004 | 42 | 0.020 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2007 | 321 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2007 | 706 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2018 | 26168 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2010 | 1174 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 2011 | 1017 | 0.010 |
Why?
|
| Etoposide | 1 | 2006 | 630 | 0.010 |
Why?
|
| Escherichia coli O157 | 1 | 2004 | 53 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2005 | 186 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2005 | 287 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2012 | 2668 | 0.010 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2005 | 377 | 0.010 |
Why?
|
| Fermentation | 1 | 2004 | 146 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2007 | 600 | 0.010 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 384 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2005 | 562 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 2422 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2005 | 1143 | 0.010 |
Why?
|
| Fatty Acids, Volatile | 1 | 2004 | 100 | 0.010 |
Why?
|
| Half-Life | 1 | 2005 | 652 | 0.010 |
Why?
|
| Genes, ras | 1 | 2007 | 654 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2005 | 413 | 0.010 |
Why?
|
| Butyrates | 1 | 2004 | 169 | 0.010 |
Why?
|
| Cell Shape | 1 | 2005 | 372 | 0.010 |
Why?
|
| Fluoxetine | 1 | 2007 | 733 | 0.010 |
Why?
|
| Smoking | 1 | 2020 | 9070 | 0.010 |
Why?
|
| Lymphopenia | 1 | 2005 | 280 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2005 | 780 | 0.010 |
Why?
|
| Mast Cells | 1 | 2011 | 1428 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 1755 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12532 | 0.010 |
Why?
|
| Homozygote | 1 | 2008 | 1786 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 11341 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2008 | 1455 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2009 | 1511 | 0.010 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2002 | 49 | 0.010 |
Why?
|
| Fibronectins | 1 | 2006 | 721 | 0.010 |
Why?
|
| Endometriosis | 1 | 2011 | 871 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2005 | 1095 | 0.010 |
Why?
|
| Young Adult | 3 | 2017 | 58673 | 0.010 |
Why?
|
| Phosphoserine | 1 | 2002 | 203 | 0.010 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2006 | 625 | 0.010 |
Why?
|
| Complement C3 | 1 | 2004 | 451 | 0.010 |
Why?
|
| Anilides | 1 | 2005 | 409 | 0.010 |
Why?
|
| Thiazolidinediones | 1 | 2005 | 465 | 0.010 |
Why?
|
| Receptors, Virus | 1 | 2005 | 639 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 2004 | 568 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2004 | 2186 | 0.010 |
Why?
|
| Registries | 1 | 2017 | 8449 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 2192 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9274 | 0.010 |
Why?
|
| Neoplasms | 1 | 2010 | 22066 | 0.010 |
Why?
|
| Dietary Fiber | 1 | 2004 | 760 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2005 | 731 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2005 | 1870 | 0.010 |
Why?
|
| Longevity | 1 | 2008 | 1050 | 0.010 |
Why?
|
| Quinazolines | 1 | 2007 | 1363 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2005 | 1033 | 0.010 |
Why?
|
| Radiography | 1 | 2011 | 6965 | 0.010 |
Why?
|
| Drug Design | 1 | 2005 | 1062 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 1346 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2008 | 2563 | 0.010 |
Why?
|
| Movement | 1 | 2006 | 1474 | 0.010 |
Why?
|
| Benzamides | 1 | 2005 | 1369 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 1995 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 1408 | 0.010 |
Why?
|
| Rabbits | 1 | 2005 | 4773 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17766 | 0.010 |
Why?
|
| Collagen | 1 | 2006 | 2635 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2005 | 1370 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2008 | 2627 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 9196 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2008 | 2623 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2006 | 1973 | 0.010 |
Why?
|
| Adolescent | 2 | 2017 | 87747 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 25928 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 4875 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 2005 | 1919 | 0.010 |
Why?
|
| Pyridines | 1 | 2005 | 2877 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 21378 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 5073 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2011 | 15680 | 0.000 |
Why?
|